Andrei I. Holodny - Concepedia

Author

Andrei I. Holodny

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

A HOLODNY, A Holodny, A I Holodny, A. Holodny, A. I. Holodny, A.I. Holodny, ANDREI I. HOLODNY, Andrei Holodny, Andrei I Holodny, Andrei I. Holodny

296

Publications

7.6K

Citations

H-Index

110

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Rutgers, The State University of New Jersey Rutgers New Jersey Medical School University Hospital, Newark

About

Andrei I. Holodny is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, neuroimaging, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	51	2.2K
2	Health Sciences	19	25	1.2K
3	Engineering	3	3	143
4	Language Studies	2	2	35
5	Arts	1	1	11

Andrei I. Holodny

127

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer Christian Grommes, Geoffrey R. Oxnard, Mark G. Kris, Neuro-Oncology	2011	341
The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. Andrei I. Holodny, Michael Schulder, Wen‐Ching Liu, PubMed	2000	256
Functional image—guided surgery of intracranial tumors located in or near the sensorimotor cortex Michael Schulder, Joseph A. Maldjian, Wen‐Ching Liu, Journal of neurosurgery	1998	218
Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients Vesselin Z. Miloushev, Kristin L. Granlund, Rostislav Boltyanskiy, Cancer Research	2018	215
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma Robert J. Young, Ajay Gupta, Akash Shah, Neurology	2011	195
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma Macarena I. de la Fuente, Robert J. Young, Jennifer Rubel, Neuro-Oncology	2015	191
Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker M. Catherine Pietanza, Kyuichi Kadota, Kety Huberman, Clinical Cancer Research	2012	182
Effect of brain tumor neovasculature defined by rCBV on BOLD fMRI activation volume in the primary motor cortex Bob L. Hou, Michelle S. Bradbury, Kyung K. Peck, NeuroImage Neuro-oncologyNeuroimaging ModalityNeuroanatomyBrain Tumor NeovasculatureNeuroimaging	2006	166
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results Jae H. Park, Karthik Nath, Sean M. Devlin, Nature Medicine Lymphoid NeoplasiaCell TherapySurgical OncologyMedicineImmunology	2023	144
Decreased BOLD functional MR activation of the motor and sensory cortices adjacent to a glioblastoma multiforme: implications for image-guided neurosurgery. Andrei I. Holodny, Michael Schulder, Wen Ching Liu, PubMed Image-guided NeurosurgeryBrain LesionGliomaSensory CorticesMagnetic Resonance Imaging	1999	141

Page 1